论文部分内容阅读
用放免法检测了 30例高血压病 (EH)患者用培垛普利治疗前后血浆心钠素 (ANP)的变化。结果显示 ,该药能明显降低EH患者血浆 ANP水平 ,其机制可能是抑制 ANP产生和释放的某个环节。
The changes of plasma atrial natriuretic peptide (ANP) before and after treatment with Pentapril in 30 patients with essential hypertension (EH) were detected by radioimmunoassay. The results show that the drug can significantly reduce plasma ANP levels in patients with EH, the mechanism may be inhibited ANP production and release of a link.